1. Home
  2. PFSA vs LGHL Comparison

PFSA vs LGHL Comparison

Compare PFSA & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profusa Inc.

PFSA

Profusa Inc.

BUY

Current Price

$1.07

Market Cap

902.5K

Sector

Health Care

ML Signal

BUY

LGHL

Lion Group Holding Ltd.

HOLD

Current Price

$3.00

Market Cap

862.9K

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFSA
LGHL
Founded
2009
2015
Country
United States
Singapore
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
902.5K
862.9K
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
PFSA
LGHL
Price
$1.07
$3.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.6M
107.5K
Earning Date
11-18-2026
04-30-2024
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.89
$0.22
52 Week High
$90,000.00
$9.54

Technical Indicators

Market Signals
Indicator
PFSA
LGHL
Relative Strength Index (RSI) 36.61 42.79
Support Level $0.89 $0.71
Resistance Level $24.50 $5.89
Average True Range (ATR) 0.23 0.60
MACD 0.31 -0.39
Stochastic Oscillator 7.79 7.57

Price Performance

Historical Comparison
PFSA
LGHL

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

About LGHL Lion Group Holding Ltd.

Lion Group Holding Ltd provides an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, and Over-The-Counter (OTC) stock options trading business. It offers these services through its all-in-one Lion Brokers Pro app and a variety of other apps available on iOS, Android, PC, and Mac platforms. The company's clients are mostly well-educated and affluent Chinese investors residing both inside and outside the PRC (excluding the United States). Its operating segments are: OTC Stock option trading, which generates maximum revenue, CFD trading, TRS trading, and Other. Geographically, the company derives maximum revenue from Hong Kong.

Share on Social Networks: